Pinnacle Associates LTD Abbott Laboratories Transaction History

Pinnacle Associates LTD

  • $6.3 Billion
  • Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Pinnacle Associates LTD holds 102,454 shares of ABT stock, worth $12.1 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
102,454
Previous 96,308 6.38%
Holding current value
$12.1 Million
Previous $10 Million 16.72%
% of portfolio
0.19%
Previous 0.16%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
BUY
$100.07 - $118.13 $615,030 - $726,026
6,146 Added 6.38%
102,454 $11.7 Million
Q2 2024

Jul 30, 2024
SELL
$100.73 - $112.44 $151,800 - $169,447
-1,507 Reduced 1.54%
96,308 $10 Million
Q1 2024

Apr 26, 2024
SELL
$109.52 - $120.96 $508,063 - $561,133
-4,639 Reduced 4.53%
97,815 $11.1 Million
Q4 2023

Jan 19, 2024
BUY
$90.19 - $110.4 $127,709 - $156,326
1,416 Added 1.4%
102,454 $11.3 Million
Q3 2023

Oct 23, 2023
SELL
$95.53 - $114.62 $376,101 - $451,258
-3,937 Reduced 3.75%
101,038 $9.79 Million
Q2 2023

Jul 26, 2023
BUY
$100.78 - $112.29 $3.67 Million - $4.09 Million
36,437 Added 53.16%
104,975 $11.4 Million
Q1 2023

May 04, 2023
BUY
$96.86 - $114.01 $563,144 - $662,854
5,814 Added 9.27%
68,538 $6.94 Million
Q4 2022

Jan 31, 2023
BUY
$95.06 - $111.52 $42,491 - $49,849
447 Added 0.72%
62,724 $6.89 Million
Q4 2022

Jan 25, 2023
BUY
$95.06 - $111.52 $488,323 - $572,878
5,137 Added 8.99%
62,277 $0
Q3 2022

Oct 31, 2022
SELL
$96.76 - $112.03 $24,093 - $27,895
-249 Reduced 0.43%
57,140 $5.53 Million
Q2 2022

Aug 02, 2022
SELL
$102.07 - $123.37 $135,242 - $163,465
-1,325 Reduced 2.26%
57,389 $6.24 Million
Q1 2022

May 05, 2022
BUY
$114.02 - $139.04 $308,880 - $376,659
2,709 Added 4.84%
58,714 $6.95 Million
Q4 2021

Feb 02, 2022
SELL
$115.53 - $141.46 $3,812 - $4,668
-33 Reduced 0.06%
56,005 $7.88 Million
Q3 2021

Oct 19, 2021
SELL
$116.66 - $129.06 $77,928 - $86,212
-668 Reduced 1.18%
56,038 $6.62 Million
Q2 2021

Aug 02, 2021
BUY
$105.79 - $124.53 $7,087 - $8,343
67 Added 0.12%
56,706 $6.57 Million
Q1 2021

May 12, 2021
SELL
$108.84 - $128.23 $43,427 - $51,163
-399 Reduced 0.7%
56,639 $6.79 Million
Q4 2020

Jan 26, 2021
BUY
$105.0 - $114.42 $15,015 - $16,362
143 Added 0.25%
57,038 $6.25 Million
Q3 2020

Oct 23, 2020
SELL
$91.64 - $111.29 $74,594 - $90,590
-814 Reduced 1.41%
56,895 $6.19 Million
Q2 2020

Aug 14, 2020
SELL
$76.57 - $98.0 $39,663 - $50,764
-518 Reduced 0.89%
57,709 $5.28 Million
Q1 2020

May 13, 2020
BUY
$62.82 - $91.86 $220,184 - $321,969
3,505 Added 6.41%
58,227 $4.6 Million
Q4 2019

Feb 03, 2020
BUY
$78.51 - $87.4 $194,233 - $216,227
2,474 Added 4.74%
54,722 $4.75 Million
Q3 2019

Nov 08, 2019
BUY
$81.84 - $88.74 $39,856 - $43,216
487 Added 0.94%
52,248 $4.37 Million
Q2 2019

Aug 05, 2019
SELL
$72.88 - $85.0 $77,835 - $90,780
-1,068 Reduced 2.02%
51,761 $4.35 Million
Q1 2019

May 10, 2019
SELL
$66.22 - $80.06 $23,375 - $28,261
-353 Reduced 0.66%
52,829 $4.22 Million
Q4 2018

Feb 05, 2019
SELL
$65.56 - $74.27 $52,841 - $59,861
-806 Reduced 1.49%
53,182 $3.85 Million
Q3 2018

Nov 13, 2018
BUY
$60.81 - $73.36 $25,053 - $30,224
412 Added 0.77%
53,988 $3.96 Million
Q2 2018

Aug 08, 2018
BUY
$57.57 - $63.54 $11,686 - $12,898
203 Added 0.38%
53,576 $3.27 Million
Q1 2018

May 11, 2018
SELL
$56.27 - $63.62 $739,894 - $836,539
-13,149 Reduced 19.77%
53,373 $3.2 Million
Q4 2017

Feb 12, 2018
SELL
$53.68 - $57.47 $107,735 - $115,342
-2,007 Reduced 2.93%
66,522 $3.8 Million
Q3 2017

Nov 13, 2017
SELL
$48.06 - $53.64 $27,874 - $31,111
-580 Reduced 0.84%
68,529 $3.66 Million
Q2 2017

Aug 09, 2017
BUY
N/A
69,109
69,109 $3.36 Million

Others Institutions Holding ABT

# of Institutions
3,185
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Pinnacle Associates LTD Portfolio

Follow Pinnacle Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email